Home-based oncology transforms practice transformation with clear bagging, protecting Medicare reimbursement, provider control, and lower costs for patients, health systems, and payers.
|Webinars|May 21, 2021
Matters in Managed Care: Bringing Equity at Birth, Part 1
In the April Matters in Managed Care webinar, leaders from Anthem and a partner of Anthem’s Doula Pilot Program in California discuss how a health plan can take an active role in reducing disparities in maternity mortality, which has been recognized by the World Health Organization as a growing health concern in the United States.
Advertisement
In the April Matters in Managed Care webinar, leaders from Anthem and a partner of Anthem’s Doula Pilot Program in California discuss how a health plan can take an active role in reducing disparities in maternity mortality, which has been recognized by the World Health Organization as a growing health concern in the United States.
The American Journal of Managed Care®'s Associate Editorial Director Mary Caffrey moderated a discussion with Demetria Malloy, MD, MSHS, medical director, plan performance (state), Anthem Blue Cross; Truc Tang, MPH, director, health equity, health education, and cultural linguistics, Anthem; Fanta Nelson, health educator, Black Infant Health Program, Fresno County Department of Health; Anna Gruver, director, Alameda County Public Health Department; and Nicole Morris, MTS, doula support services coordinator, Alameda County Public Health Department.
In segment 1, panelists discuss Anthem’s approach.
Advertisement
Related to this article
Costs of multimorbidity in older adults are climbing faster than its disability toll, and study authors say policy should look past single-disease programs.
An analysis of AccessHope case reviews found that experts recommended changes in more than 80% of cases. About half were implemented, saving a median of $18,636 per case.
Early modeling put sickle cell gene therapy coverage near 11 cents per member per month.
At an AJMC® Stakeholder Interchange in Los Angeles, leukemia specialists described a region where hospital formularies push menin inhibitor starts into the clinic, emergency department (ED) physicians may not recognize differentiation syndrome, and capitated insurance contracts steer some patients with acute myeloid leukemia away from academic centers.
At AMCP Nexus 2026, payers said evidence, differentiation, and delivery now matter as much as FDA approval.
A poster at the ASCO Quality Care Symposium describes how a value-based care partnership used prior authorization data and pharmacist workflows to move eligible patients off flat dosing of pembrolizumab.
Advertisement
Advertisement
Trending on AJMC
1
Four Major Idiopathic Pulmonary Fibrosis Advances From 2026
2
Kidney Week 2026 Recap: IgAN Advances, Value-Based Care, CKD Care Gaps
3
Elagolix Noninferior to Dienogest for Endometriosis Pain in Phase 3 Trial
4
FAQ: PBM Reform, 340B, and Medicare Shifts Payers Face in 2027
5